Based on the KEGG terms, the therapeutic targets of C. religiosa against DN are primarily linked to the PI3K-Akt signaling pathway, Insulin resistance, insulin signaling pathways, AGE-RAGE signaling pathway in diabetic complications, and IL17 signaling pathway. This evidence concerns the gene RENBP and liver dysplastic nodule.